bone and wound infections Flashcards
what percentage of HAIs are surgical site infections
15%
major pathogens causing SSIs?
staphaylococcus aureus, e coli, p. aeruginosa
Intra operative
Limit number of people in theatre (people shed skin cells)
Ventilation of theatre (positive pressure) laminar flow for orthopaedics
Sterilisation of Surgical Instruments
Skin Preparation:
• Povidine-iodine
• Chlorhexidine (in 70% alcohol)
Asepsis and Surgical Technique
• Remove all dead tissue
• IV devices should follow aseptic procedures
Normothermia (if <36C, consider warming):
• Hypothermia increase risk of SSIs by causing vasoconstriction and decreasing oxygen delivery to wound space with impairment of neutrophil function
• Measure the patient’s temperature before inducing anaesthesia
Oxygenation
• SpO2 >95%
• Higher O2 saturations reduced SSIs
septic arthritis risk factors
o Risk Factors:
Rheumatoid arthritis Osteoarthritis
Crystal arthritis Joint prosthesis
IVDU Diabetes, chronic renal disease, chronic liver disease
Immunosuppression (e.g. steroids) Trauma – intra-articular injection, penetrating injury
Pathophysiology of septic arthritis
o Organisms adhere to synovium
o Bacterial proliferation in synovial fluid host inflammatory response joint damage
o Joint damage exposure of host derived protein (e.g. fibronectin) to which bacteria can adhere
o Bacterial Factors:
S. aureus has receptors such as fibronectin-binding protein that recognise selected host proteins
S. aureus (some strains) produce cytotoxin PVL (Panton-Valentine Leucocidin) fulminant infection
Kingella kingae synovial adherence is via bacterial pili
what host factors cause damage in septic arthritis
o Host Factors:
Leucocyte derived proteases and cytokines can cause cartilage and bone damage
Raised intra-articular pressure impedes capillary blood flow cartilage and bone ischaemia/necrosis
Genetic deletion of macrophage-derived cytokines reduce host-response in S. aureus sepsis
Absence of IL-10 increases the severity of staphylococcus joint disease
causes of septic arthritis
o Staphylococcus aureus 46%
o Streptococci: 22%
Streptococcus pyogenes
Streptococcus pneumoniae
Streptococcus agalactiae
o Gram-negative organisms:
Escherichia coli Haemophilus influenzae
Neisseria gonorrhoea Salmonella
o Coagulase-negative staphylococci 4%
o Lyme disease, Brucellosis, Mycobacteria, Fungi Rare
vertebral osteomyelitis causes
• Causes:
o Acute haematogenous spread (bacteraemia)
o Exogenous (after disc surgery, implant associated)
• Causative organisms: o Staphylococcus aureus (48.3%) o Coagulase-negative staphylococcus o Gram-negative rods o Streptococcus
treatment of chronic osteomyelitis
• Treatment = radical debridement to living bone:
o Modified Lautenbach technique:
Debridement and collection of multiple samples for culture and histology
All foreign prosthetic material is removed
Debridement done all the way down to healthy bleeding bone (check using osteoscopy)
Double lumen irrigation system is introduced through a subcutaneous tunnel
Antibiotics (chosen based on culture results) instilled into affected bone through the central lumen
Every week 1 L of Hartmann’s solution is infused through each drain and suction fluid is sent for culture
Irrigation is continued for 3 weeks
o Oral ABx (up to 6 weeks after discharge)
o Papineau Technique:
Complete excision of infected tissue and necrotic bone
Followed by open cancellous bone grafting of the osseous defect
Split skin grafting is used to close the wound
Success rate of 89-93%
prosthetic joint infection causative organisms
• Causative Organisms: o Gram-positive cocci: Coagulase-negative staphylococci > S. aureus Streptococci Enterococci o Aerobic Gram-negative bacilli: Enterobacteriaceae Pseudomonas aeruginosa o Anaerobes o Polymicrobials o Culture-negative o Fungi
Diagnosis prosthetic joint infection
• Diagnosis:
o Radiology – loosening (bone loss along the cement-bone interface)
o Raised CRP:
CRP >13.5 for prosthetic knee joint infection
CRP >5 for prosthetic hip joint infection
o Joint Aspiration:
If >1,700 WCC/mL knee PJI
If >4,200 WCC/mL hip PJI
o Intraoperative Microbiological Sampling:
Tissue specimens taken from at least 5 sites around the implant
Histopathology (if >3 specimens yield identical organisms suggestive of PJI)
treatment of prosthetic joint
o Single Stage Revision (i.e. Endo-Klinik):
Remove all foreign material and dead bone
Change gloves and drapes etc.
Re-implant new prosthesis with antibiotic impregnated cement and give IV antibiotics
o Two Stage Revision:
Remove prosthesis and put in a spacer (to take up the space of the prosthesis)
Take samples for microbiology and histology
Period of IV antibiotics (for 6 weeks) then stop antibiotics for 2 weeks
Re-debride and sample at second stage
Re-implantation with antibiotic impregnated cement
NO further antibiotics needed if the samples are clear
• If antibiotics are required, OPAT is used